Tomoyuki Furubayashi

1.5k total citations
39 papers, 1.2k citations indexed

About

Tomoyuki Furubayashi is a scholar working on Pharmaceutical Science, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tomoyuki Furubayashi has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmaceutical Science, 8 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tomoyuki Furubayashi's work include Advanced Drug Delivery Systems (21 papers), Drug Solubulity and Delivery Systems (16 papers) and Drug Transport and Resistance Mechanisms (7 papers). Tomoyuki Furubayashi is often cited by papers focused on Advanced Drug Delivery Systems (21 papers), Drug Solubulity and Delivery Systems (16 papers) and Drug Transport and Resistance Mechanisms (7 papers). Tomoyuki Furubayashi collaborates with scholars based in Japan, United Kingdom and United States. Tomoyuki Furubayashi's co-authors include Toshiyasu Sakane, Shinji Yamashita, Makoto Kataoka, Hitoshi Sezaki, Hideaki Tokuda, Daisuke Inoue, Akiko Tanaka, Hidemasa Katsumi, Shunsuke Kimura and Akira Yamamoto and has published in prestigious journals such as PLoS ONE, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Tomoyuki Furubayashi

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoyuki Furubayashi Japan 17 491 298 236 141 129 39 1.2k
Toyofumi Suzuki Japan 20 487 1.0× 329 1.1× 160 0.7× 36 0.3× 127 1.0× 90 1.3k
Erik Björk Sweden 32 986 2.0× 531 1.8× 132 0.6× 150 1.1× 120 0.9× 57 2.4k
Charan Singh India 19 320 0.7× 465 1.6× 117 0.5× 173 1.2× 63 0.5× 90 1.4k
Mónika Vastag Hungary 18 142 0.3× 311 1.0× 228 1.0× 46 0.3× 140 1.1× 42 1.1k
Takayoshi Yoshikawa Japan 16 464 0.9× 519 1.7× 311 1.3× 34 0.2× 196 1.5× 29 1.5k
Peipei Guan China 22 406 0.8× 674 2.3× 134 0.6× 75 0.5× 122 0.9× 83 1.8k
Alexandra Bocsik Hungary 17 293 0.6× 240 0.8× 122 0.5× 87 0.6× 46 0.4× 26 860
Bhavin Vyas India 21 656 1.3× 339 1.1× 47 0.2× 91 0.6× 97 0.8× 65 1.5k
Sunday Shoyele United States 17 462 0.9× 608 2.0× 131 0.6× 372 2.6× 53 0.4× 27 1.5k
Libero Italo Giannola Italy 18 540 1.1× 234 0.8× 51 0.2× 47 0.3× 103 0.8× 61 1.2k

Countries citing papers authored by Tomoyuki Furubayashi

Since Specialization
Citations

This map shows the geographic impact of Tomoyuki Furubayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Furubayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Furubayashi more than expected).

Fields of papers citing papers by Tomoyuki Furubayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoyuki Furubayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Furubayashi. The network helps show where Tomoyuki Furubayashi may publish in the future.

Co-authorship network of co-authors of Tomoyuki Furubayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyuki Furubayashi. A scholar is included among the top collaborators of Tomoyuki Furubayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyuki Furubayashi. Tomoyuki Furubayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Furubayashi, Tomoyuki, et al.. (2025). Efficacy of intranasal delivery of VEGFR inhibitors to cervical lymph nodes for inhibiting tongue cancer metastasis in mice. Journal of drug targeting. 33(10). 1932–1941.
2.
Seino, Satoshi, Tomohiro Umeda, Takami Tomiyama, et al.. (2024). Investigating the efficacy of nasal administration for delivering magnetic nanoparticles into the brain for magnetic particle imaging. Journal of Controlled Release. 367. 515–521. 10 indexed citations
3.
Tanaka, Akiko, et al.. (2024). Changes in Tablet Color Due to Light Irradiation: Photodegradation of the Coating Polymer, Hypromellose, by Titanium Dioxide. AAPS PharmSciTech. 25(1). 26–26. 5 indexed citations
4.
Tanaka, Akiko, Nahoko Kato‐Kogoe, Koji Yamanegi, et al.. (2023). Topical Administration of Freeze-Dried Sheets of Hyaluronic Acid Promotes the Healing of Oral Mucositis in a Hamster Model. Journal of Hard Tissue Biology. 32(4). 223–230.
5.
Sakane, Toshiyasu, Sachi Okabayashi, Shunsuke Kimura, et al.. (2020). Brain and Nasal Cavity Anatomy of the Cynomolgus Monkey: Species Differences from the Viewpoint of Direct Delivery from the Nose to the Brain. Pharmaceutics. 12(12). 1227–1227. 10 indexed citations
6.
Inoue, Daisuke, Tomoyuki Furubayashi, Akiko Tanaka, Toshiyasu Sakane, & Kiyohiko Sugano. (2020). Effect of Cerebrospinal Fluid Circulation on Nose-to-Brain Direct Delivery and Distribution of Caffeine in Rats. Molecular Pharmaceutics. 17(11). 4067–4076. 19 indexed citations
7.
Inoue, Daisuke, Tomoyuki Furubayashi, Akiko Tanaka, Toshiyasu Sakane, & Kiyohiko Sugano. (2020). Quantitative estimation of drug permeation through nasal mucosa using in vitro membrane permeability across Calu-3 cell layers for predicting in vivo bioavailability after intranasal administration to rats. European Journal of Pharmaceutics and Biopharmaceutics. 149. 145–153. 37 indexed citations
8.
9.
Inoue, Daisuke, Akiko Tanaka, Shunsuke Kimura, et al.. (2018). The relationship between in vivo nasal drug clearance and in vitro nasal mucociliary clearance: Application to the prediction of nasal drug absorption. European Journal of Pharmaceutical Sciences. 117. 21–26. 25 indexed citations
10.
Tanaka, Akiko, Tomoyuki Furubayashi, Mari Arai, et al.. (2018). Delivery of Oxytocin to the Brain for the Treatment of Autism Spectrum Disorder by Nasal Application. Molecular Pharmaceutics. 15(3). 1105–1111. 72 indexed citations
11.
Tanaka, Akiko, Tomoyuki Furubayashi, Shunsuke Kimura, et al.. (2016). Nasal drug absorption from powder formulations: The effect of three types of hydroxypropyl cellulose (HPC). European Journal of Pharmaceutical Sciences. 96. 284–289. 39 indexed citations
12.
Shingaki, Tomotaka, Yumiko Katayama, Takayoshi Nakaoka, et al.. (2015). Visualization of drug translocation in the nasal cavity and pharmacokinetic analysis on nasal drug absorption using positron emission tomography in the rat. European Journal of Pharmaceutics and Biopharmaceutics. 99. 45–53. 10 indexed citations
13.
Nagai, Miho, Shunsuke Kimura, Takanori Yamamoto, et al.. (2011). The disposition and intestinal absorption of zinc in rats. European Journal of Pharmaceutical Sciences. 44(3). 410–415. 16 indexed citations
14.
Shingaki, Tomotaka, Ismael J. Hidalgo, Tomoyuki Furubayashi, et al.. (2011). Nasal Delivery of P-gp Substrates to the Brain through the Nose–Brain Pathway. Drug Metabolism and Pharmacokinetics. 26(3). 248–255. 21 indexed citations
15.
Shingaki, Tomotaka, Daisuke Inoue, Tomoyuki Furubayashi, et al.. (2010). Transnasal Delivery of Methotrexate to Brain Tumors in Rats: A New Strategy for Brain Tumor Chemotherapy. Molecular Pharmaceutics. 7(5). 1561–1568. 55 indexed citations
16.
Shingaki, Tomotaka, Ismael J. Hidalgo, Tomoyuki Furubayashi, et al.. (2009). The transnasal delivery of 5-fluorouracil to the rat brain is enhanced by acetazolamide (the inhibitor of the secretion of cerebrospinal fluid). International Journal of Pharmaceutics. 377(1-2). 85–91. 26 indexed citations
17.
Ooya, Tooru, et al.. (2007). Cationic hydrogels of PEG crosslinked by a hydrolyzable polyrotaxane for cartilage regeneration. Reactive and Functional Polymers. 67(11). 1408–1417. 25 indexed citations
18.
Furubayashi, Tomoyuki, et al.. (2007). Influence of Formulation Viscosity on Drug Absorption Following Nasal Application in Rats. Drug Metabolism and Pharmacokinetics. 22(3). 206–211. 47 indexed citations
19.
Furubayashi, Tomoyuki, et al.. (2004). Novel biodegradable cholesterol-modified polyrotaxane hydrogels for cartilage regeneration. Journal of Biomaterials Science Polymer Edition. 15(11). 1389–1404. 16 indexed citations
20.
Yamashita, Shinji, Tomoyuki Furubayashi, Makoto Kataoka, et al.. (2000). Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. European Journal of Pharmaceutical Sciences. 10(3). 195–204. 467 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toyofumi Suzuki Breakdown of academic impact, for papers by Erik Björk Breakdown of academic impact, for papers by Charan Singh Breakdown of academic impact, for papers by Mónika Vastag Breakdown of academic impact, for papers by Takayoshi Yoshikawa Breakdown of academic impact, for papers by Peipei Guan Breakdown of academic impact, for papers by Alexandra Bocsik Breakdown of academic impact, for papers by Bhavin Vyas Breakdown of academic impact, for papers by Sunday Shoyele Breakdown of academic impact, for papers by Libero Italo Giannola
Rankless by CCL
2026